
Hasan Syed Ahmed
Examiner (ID: 2321, Phone: (571)272-4792 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | PIA, 1618, 1615 |
| Total Applications | 773 |
| Issued Applications | 311 |
| Pending Applications | 26 |
| Abandoned Applications | 436 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11046314
[patent_doc_number] => 20160243272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'SURGICAL ADHESIVE AND USES THEREFORE'
[patent_app_type] => utility
[patent_app_number] => 15/145081
[patent_app_country] => US
[patent_app_date] => 2016-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10056
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15145081
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/145081 | SURGICAL ADHESIVE AND USES THEREFORE | May 2, 2016 | Abandoned |
Array
(
[id] => 12786550
[patent_doc_number] => 20180154019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => COMPOSITIONS AND METHODS FOR ADMINISTERING ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 15/570504
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -72
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570504
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570504 | Compositions and methods for administering antibodies | Apr 28, 2016 | Issued |
Array
(
[id] => 11023562
[patent_doc_number] => 20160220517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'Abuse-proofed oral dosage form'
[patent_app_type] => utility
[patent_app_number] => 15/095336
[patent_app_country] => US
[patent_app_date] => 2016-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10116
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15095336
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/095336 | Abuse-proofed oral dosage form | Apr 10, 2016 | Abandoned |
Array
(
[id] => 11362747
[patent_doc_number] => 20170000728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders'
[patent_app_type] => utility
[patent_app_number] => 15/091148
[patent_app_country] => US
[patent_app_date] => 2016-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 50688
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15091148
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/091148 | Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders | Apr 4, 2016 | Abandoned |
Array
(
[id] => 11520583
[patent_doc_number] => 09603964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Hemostatic devices'
[patent_app_type] => utility
[patent_app_number] => 15/071520
[patent_app_country] => US
[patent_app_date] => 2016-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 20452
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071520
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/071520 | Hemostatic devices | Mar 15, 2016 | Issued |
Array
(
[id] => 13925897
[patent_doc_number] => 20190046464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => ADHESIVE PATCH
[patent_app_type] => utility
[patent_app_number] => 16/085048
[patent_app_country] => US
[patent_app_date] => 2016-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085048
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085048 | Adhesive patch | Mar 15, 2016 | Issued |
Array
(
[id] => 10820353
[patent_doc_number] => 20160166517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'ABUSE-PROOFED DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 15/054201
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11558
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15054201
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/054201 | ABUSE-PROOFED DOSAGE FORM | Feb 25, 2016 | Abandoned |
Array
(
[id] => 11527114
[patent_doc_number] => 20170087091
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-03-30
[patent_title] => 'ACCORDION PILL COMPRISING LEVODOPA FOR AN IMPROVED TREATMENT OF PARKINSON\'S DISEASE SYMPTOMS'
[patent_app_type] => utility
[patent_app_number] => 15/014854
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13300
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15014854
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/014854 | Accordion pill comprising levodopa for an improved treatment of Parkinson's disease symptoms | Feb 2, 2016 | Issued |
Array
(
[id] => 11527114
[patent_doc_number] => 20170087091
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-03-30
[patent_title] => 'ACCORDION PILL COMPRISING LEVODOPA FOR AN IMPROVED TREATMENT OF PARKINSON\'S DISEASE SYMPTOMS'
[patent_app_type] => utility
[patent_app_number] => 15/014854
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13300
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15014854
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/014854 | Accordion pill comprising levodopa for an improved treatment of Parkinson's disease symptoms | Feb 2, 2016 | Issued |
Array
(
[id] => 10797135
[patent_doc_number] => 20160143292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'Anti-Microbial Compositions and Methods'
[patent_app_type] => utility
[patent_app_number] => 15/013455
[patent_app_country] => US
[patent_app_date] => 2016-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12590
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15013455
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/013455 | Anti-Microbial Compositions and Methods | Feb 1, 2016 | Abandoned |
Array
(
[id] => 11348743
[patent_doc_number] => 20160367483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 15/004471
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15918
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15004471
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/004471 | MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION | Jan 21, 2016 | Abandoned |
Array
(
[id] => 11113460
[patent_doc_number] => 20160310432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 15/004461
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16708
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15004461
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/004461 | MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION | Jan 21, 2016 | Abandoned |
Array
(
[id] => 11407706
[patent_doc_number] => 09554991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-31
[patent_title] => 'Carbidopa/levodopa gastroretentive drug delivery'
[patent_app_type] => utility
[patent_app_number] => 14/995611
[patent_app_country] => US
[patent_app_date] => 2016-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 10829
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14995611
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/995611 | Carbidopa/levodopa gastroretentive drug delivery | Jan 13, 2016 | Issued |
Array
(
[id] => 13440965
[patent_doc_number] => 20180272025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => Dressing
[patent_app_type] => utility
[patent_app_number] => 15/542865
[patent_app_country] => US
[patent_app_date] => 2016-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542865
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542865 | Dressing | Jan 10, 2016 | Abandoned |
Array
(
[id] => 14818381
[patent_doc_number] => 10406176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Mineral, nutritional, cosmetic, pharmaceutical, and agricultural compositions and methods for producing the same
[patent_app_type] => utility
[patent_app_number] => 14/992575
[patent_app_country] => US
[patent_app_date] => 2016-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10502
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14992575
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/992575 | Mineral, nutritional, cosmetic, pharmaceutical, and agricultural compositions and methods for producing the same | Jan 10, 2016 | Issued |
Array
(
[id] => 11330891
[patent_doc_number] => 09522122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-20
[patent_title] => 'Multilaminate backing construction'
[patent_app_type] => utility
[patent_app_number] => 14/980383
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7175
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14980383
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/980383 | Multilaminate backing construction | Dec 27, 2015 | Issued |
Array
(
[id] => 11113474
[patent_doc_number] => 20160310446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/970421
[patent_app_country] => US
[patent_app_date] => 2015-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10519
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14970421
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/970421 | Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof | Dec 14, 2015 | Abandoned |
Array
(
[id] => 10812116
[patent_doc_number] => 20160158275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/968170
[patent_app_country] => US
[patent_app_date] => 2015-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 58118
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14968170
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/968170 | PHARMACEUTICAL COMPOSITIONS | Dec 13, 2015 | Abandoned |
Array
(
[id] => 17554914
[patent_doc_number] => 11311571
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Proton-binding polymers for oral administration
[patent_app_type] => utility
[patent_app_number] => 15/533705
[patent_app_country] => US
[patent_app_date] => 2015-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 61801
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15533705
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/533705 | Proton-binding polymers for oral administration | Dec 9, 2015 | Issued |
Array
(
[id] => 11262199
[patent_doc_number] => 09486480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Surface-modified heavy metal nanoparticles, compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/962664
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 13099
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962664
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/962664 | Surface-modified heavy metal nanoparticles, compositions and uses thereof | Dec 7, 2015 | Issued |